CDKN2A and astrocytoma (excluding glioblastoma): According to cIMPACT-NOW update 5 and the upcoming WHO classification for tumors of the central nervous system, homozygous CDKN2A/B deletions correspond to WHO CNS grade 4 in IDH-mutant astrocytomas [23, 8].